Arena Pharmaceuticals (ARNA) 8-K Other events

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  June 7, 2004

ARENA PHARMACEUTICALS, INC.

(Exact Name of Registrant as Specified in Charter)

DELAWARE	000-31161	23-2908305
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)
6166 Nancy Ridge Drive, San Diego, California 92121
(Address of Principal Executive Offices)   (Zip Code)
(858) 453-7200
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)

Item 5.  Other Events.

Nigel R.A. Beeley, Ph.D. has resigned as Arena Pharmaceuticals, Inc.’s Vice President and head of medicinal chemistry to join Senomyx, Inc., a San Diego based biotechnology company, as Vice President, Discovery.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 7, 2004	Arena Pharmaceuticals, Inc.,
	a Delaware corporation
	By:	/s/ Jack Lief
		Jack Lief
		President & Chief Executive Officer

2